45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,018
Insurances with rates
5
CPT / HCPCS codes
1,738
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $56,586 | $39,610 | — | — | 10 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $46,968 | $32,878 | — | — | 10 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $46,257 | $32,380 | — | — | 10 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $43,696 | $30,587 | — | — | 10 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $42,427 | $29,699 | — | — | 10 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $40,091 | $28,063 | — | — | 10 |
| J2997 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $35,201 | $24,641 | — | — | 10 |
| J9228 | IPILIMUMAB 5 MG/ML INTRAVENOUS SOLUTION (WRAPPED) | $34,813 | $24,369 | — | — | 10 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $34,666 | $24,266 | — | — | 10 |
| J9223 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $32,120 | $22,484 | — | — | 10 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $31,310 | $21,917 | — | — | 10 |
| J9308 | RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION | $29,136 | $20,395 | — | — | 10 |
| J1459 | PRIVIGEN 10 % INTRAVENOUS SOLUTION | $28,966 | $20,276 | — | — | 10 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $26,107 | $18,275 | — | — | 10 |
| J2506 | PEGFILGRASTIM 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUTANEOUS INJECTOR | $25,672 | $17,970 | — | — | 10 |
| J9217 | LEUPROLIDE 22.5 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT | $24,529 | $17,170 | — | — | 10 |
| J0717 | CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT | $22,877 | $16,014 | — | — | 10 |
| J1950 | LEUPROLIDE 11.25 MG (3 MONTH) INTRAMUSCULAR SYRINGE KIT | $20,584 | $14,409 | — | — | 10 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $19,132 | $13,392 | — | — | 10 |
| J9312 | RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS | $18,790 | $13,153 | — | — | 10 |
| 22513 | HC Pro Perq Vert Agmntj Cavity Crtj Uni/Bi Cannulation | $18,730 | $13,111 | — | — | 10 |
| 22514 | HC Pro Perq Vert Agmntj Cavity Crtj Uni/Bi Cannulj Lmbr | $18,730 | $13,111 | — | — | 10 |
| J2353 | OCTREOTIDE,MICROSPHERES ER 20 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $18,465 | $12,926 | — | — | 10 |
| Q5115 | RITUXIMAB-ABBS 10 MG/ML INTRAVENOUS SOLUTION | $16,911 | $11,838 | — | — | 10 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $16,700 | $11,690 | — | — | 10 |
| J9173 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $16,512 | $11,558 | — | — | 10 |
| J9305 | PEMETREXED DISODIUM 500 MG INTRAVENOUS POWDER FOR SOLUTION | $16,172 | $11,320 | — | — | 10 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $15,723 | $11,006 | — | — | 10 |
| Q5119 | RITUXIMAB-PVVR 10 MG/ML INTRAVENOUS SOLUTION | $14,336 | $10,035 | — | — | 10 |
| Q5123 | RITUXIMAB-ARRX 10 MG/ML INTRAVENOUS SOLUTION | $14,336 | $10,035 | — | — | 10 |
| J2182 | MEPOLIZUMAB 100 MG SUBCUTANEOUS SOLUTION | $13,852 | $9,696 | — | — | 10 |
| J9299 | NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION | $12,724 | $8,907 | — | — | 10 |
| J0630 | CALCITONIN (SALMON) 200 UNIT/ML INJECTION SOLUTION | $12,528 | $8,770 | — | — | 10 |
| 7500000006 | HC Endo Level 6 | $12,500 | $8,750 | — | — | 10 |
| J9033 | BENDAMUSTINE 100 MG INTRAVENOUS POWDER FOR SOLUTION | $11,887 | $8,321 | — | — | 10 |
| J9027 | CLOFARABINE 1 MG/ML INTRAVENOUS SOLUTION | $11,739 | $8,217 | — | — | 10 |
| J0129 | ABATACEPT (WITH MALTOSE) 250 MG INTRAVENOUS SOLUTION | $11,700 | $8,190 | — | — | 10 |
| J9205 | IRINOTECAN LIPOSOMAL 4.3 MG/ML INTRAVENOUS | $11,646 | $8,152 | — | — | 10 |
| Q5107 | BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION | $11,164 | $7,814 | — | — | 10 |
| L8699 | LINX 15 TITANIUM BEAD DEVICE IMPLANT 1.5 TESLA STATIC MAGNETIC FIELD STERILE | $11,000 | $7,700 | — | — | 10 |
| C1889 | SEROSAFUSE FASTNR KIT | $10,990 | $7,693 | — | — | 10 |
| J3111 | ROMOSOZUMAB-AQQG 210 MG/2.34 ML(105 MG/1.17 ML X2)SUBCUTANEOUS SYRINGE | $10,015 | $7,010 | — | — | 10 |
| 3600000005 | Or Time - Initial Base Charge - Procedure Level Five | $10,000 | $7,000 | — | — | 10 |
| 7500000005 | HC Endo Level 5 | $10,000 | $7,000 | — | — | 10 |
| 22515 | HC Pro Perq Vert Agmntj Cavity Crtj Uni/Bi Cannulj Each | $9,979 | $6,985 | — | — | 10 |
| J9036 | BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION | $9,895 | $6,927 | — | — | 10 |
| Q5108 | PEGFILGRASTIM-JMDB 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $8,350 | $5,845 | — | — | 10 |
| J3358 | USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION | $8,098 | $5,669 | — | — | 10 |
| J9207 | IXABEPILONE 15 MG INTRAVENOUS SOLUTION | $7,900 | $5,530 | — | — | 10 |
| 3600000004 | Or Time - Initial Base Charge - Procedure Level Four | $7,500 | $5,250 | — | — | 10 |
Showing top 50 of 2,018 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.